Share
Market Research Report

ENTERAL FEEDING DEVICES MARKET SIZE AND SHARE ANALYSIS - GROWTH TRENDS AND FORECASTS (2026-2033)

Segmentation
  • By Product TypeFeeding Tubes (Nasogastric Tube with ENFit Connector, Orogastric Tube, Nasoenteric Tube: Nasojejunal, Nasoduodenal, Oroenteric Tube, Gastrostomy Tube (G Tube) with ENFit Connector: PEG (Percutaneous Endoscopic Gastrostomy) Tube, PRG (Percutaneous Radiologic Gastrostomy) Tube, Button Tubes, Jejunostomy Tubes: PEJ (Percutaneous Endoscopic Jejunostomy) Tube, PRJ (Percutaneous Radiologic Jejunostomy) Tube) · Feeding Pumps (Peristaltic Silicone) · Administration Reservoir · Extension Feeding Set: With ENFit Connector · Without ENFit Connector · Enteral Syringes · Others
  • By Age GroupPediatric · Adults
  • By ApplicationDiabetes · Oncology · Gastrointestinal Diseases · Hypermetabolism · Others
  • By End UserHospitals · Ambulatory Surgical Centers · Others
  • By GeographyNorth America · Europe · Asia Pacific · Latin America · Middle East · and Africa
  • Published In01 Apr 2026
  • Report CodeCMI392
  • Pages250+
  • FormatsExcel and PDF
  • Base Year2025
  • Estimated Year2026
  • Historical Range2020 - 2024
  • Forecast Period2026-2033

Market Segmentation

  • By Product Type (Revenue, USD Bn, 2021 - 2033)

    • Feeding Tubes
      • Nasogastric Tube with ENFit Connector
      • Orogastric Tube
      • Nasoenteric Tube
        • Nasojejunal
        • Nasoduodenal
      • Oroenteric Tube
      • Gastrostomy Tube (G Tube) with ENFit Connector
        • PEG (Percutaneous Endoscopic Gastrostomy) Tube
        • PRG (Percutaneous Radiologic Gastrostomy) Tube
        • Button Tubes
      • Jejunostomy Tubes
        • PEJ (Percutaneous Endoscopic  Jejunostomy) Tube
        • PRJ (Percutaneous Radiologic Jejunostomy) Tube
    • Feeding Pumps (Peristaltic Silicone)
    • Administration Reservoir
    • Extension Feeding Set
      • With ENFit Connector
      • Without ENFit Connector
    • Enteral Syringes
    • Others
  • By Age Group (Revenue, USD Bn, 2021 - 2033)

    • Pediatric
    • Adults
  • By Application (Revenue, USD Bn, 2021 - 2033)

    • Diabetes
    • Oncology
    • Gastrointestinal Diseases
    • Hypermetabolism
    • Others
  • By End User (Revenue, USD Bn, 2021 - 2033)

    • Hospital
    • Ambulatory Surgical Centers
    • Others
  • By Region (Revenue, USD Bn, 2021 - 2033)

    • North America
      • U.S.
      • Canada
    • Latin America
      • Brazil
      • Argentina
      • Mexico
      • Rest of Latin America
    • Europe
      • Germany
      • U.K.
      • Spain
      • France
      • Italy
      • Russia
      • Rest of Europe
    • Asia Pacific
      • China
      • India
      • Japan
      • Australia
      • South Korea
      • ASEAN
      • Rest of Asia Pacific
    • Middle East
      • GCC Countries
      • Israel
      • Rest of Middle East
    • Africa
      • South Africa
      • North Africa
      • Central Africa